Boobalan Pachaiyappan
Stock Analyst at Roth MKM
(0)
# 4818
Out of 5,218 analysts
4
Total ratings
0.00%
Success rate
-24.82%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
CervoMed | Initiates Coverage On: Buy | 45 | 1.91 | 2256.02% | 1 | Dec 5, 2024 | |
Entrada Therapeutics | Initiates Coverage On: Buy | 29 | 17.68 | 64.03% | 1 | Dec 5, 2024 | |
Gain Therapeutics | Initiates Coverage On: Buy | 7 | 1.63 | 329.45% | 1 | Dec 5, 2024 | |
Longeveron | Initiates Coverage On: Buy | 10 | 1.84 | 443.48% | 1 | Dec 5, 2024 |